Govt Job for Ph.D, M.Pharm as Scientist at Govt of India Enterprise

HLL Lifecare Limited (HLL) is a Govt. of India Healthcare products manufacturing and services Company based in Thiruvananthapuram, Kerala, India under the Union Ministry of Health and Family Welfare.

HLL is a global leader in the area of contraceptives, hospital products and healthcare services. With 7 manufacturing units, 7 subsidiary companies, 22 regional offices and having presence in more than 115 countries, HLL is positioned as a total healthcare solution provider catering to the well-being of the society at large.

Post : SCIENTIST E3

Job Description
1. Development of drug delivery systems/ implants for regulated markets
2. Preparation of dossier for regulatory submissions for obtaining marketing clearance in regulated markets
3. Scale up and Technology Transfer
4. Meeting audit as per regulatory requirements

Candidate Profile
Maximum Age: 40 years as on 01.07.2021
Consolidated pay range (For Fixed Term Contract engagement): 35,000 –65,000/- (Senior Manager (E3) per month.

(The consolidated pay will be fixed within the pay range depending on the qualification, experience and the current pay drawn by the candidate. The consolidated pay will be inclusive of all allowances and benefits).

Educational Qualification:
Essential: PhD in Pharmaceutics/ M.Pharm Pharmaceutics

Experience
Essential: Minimum 5 years post qualification for PhD/ Minimum 8 Years post qualification experience for M.Pharm
Desirable: Patents, Technology transfers in novel drug delivery systems

General Conditions
• SC/ST/OBC/PwD candidates will be eligible for relaxation as per Government of India directives.
• Canvassing in any form will be a disqualification.

Location : Anywhere in India

Last Date : 28th July, 2021

Reference Code HLL/HR/015/2021

Related Posts

Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

Pune:  After the use of steroids for routine viral fevers and mild respiratory infections has grown among people, doctors in the city warned that it could increase the risk of…

Spurious cosmetic packaging factory busted in northwest Delhi

New Delhi: In a significant breakthrough under ‘Operation Kavach,’ the Cyber Cell of the Crime Branch, Delhi, has unearthed a major illegal manufacturing unit involved in the fabrication of empty…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

Spurious cosmetic packaging factory busted in northwest Delhi

Spurious cosmetic packaging factory busted in northwest Delhi

Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

UP plans US FDA-accredited medical device testing lab

UP plans US FDA-accredited medical device testing lab

Patent rejected for MNC’s cancer drug, generics to follow

Patent rejected for MNC’s cancer drug, generics to follow

Zydus brings world’s first Nivolumab biosimilar to India

Zydus brings world’s first Nivolumab biosimilar to India